Keyphrases
Acute Myeloid Leukemia
66%
Epigenetic Reprogramming
66%
Epigenetics
38%
Epigenomics
38%
Advanced Solid Tumors
33%
Cancer Patients
33%
Undifferentiated Pleomorphic Sarcoma
33%
Tumor Cell Subpopulations
33%
Phase I Trial
33%
Potential Biomarkers
33%
Drug Target
33%
Bivalent Chromatin
33%
Biomarkers of Response
33%
Ovarian Cancer
33%
PTGIS
33%
T Cells
33%
Cancer Immunotherapy
33%
IACS-010759
33%
Oxidative Phosphorylation (OXPHOS)
33%
Epigenetic Drugs
33%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
33%
Complex I Inhibitors
33%
Antigen Identification
33%
Synapse
33%
H3K27 Acetylation
33%
Colorectal Cancer
33%
5-azacytidine
33%
BRAF V600E
33%
H3K4 Methylation
33%
DNA Methylation (DNAm)
33%
Resistance Mechanisms
33%
Natural Killer Cells
33%
Epigenetic Modification
32%
Tumor
31%
Gene Expression
26%
Curcumin
22%
Tumor Progression
22%
5-Aza-dC
22%
Residual Tumor
22%
Complementary DNA (cDNA)
20%
T Cell Receptor
20%
Sarcoma
20%
Heterogeneity in Responses
16%
Tumor Immune Microenvironment
16%
Immuno-oncology
16%
Disease-related
16%
Reoccurrence
16%
NewHope
16%
Immune-related Adverse Effects
16%
Biomolecules
16%
Biochemistry, Genetics and Molecular Biology
Reprogramming
100%
Epigenetics
78%
Enhancer Region
70%
Epigenome
43%
DNA Methylation
40%
Drug Targeting
33%
DNA Condensation
33%
Bivalent Chromatin
33%
Alpha Thalassemia/Mental Retardation X-Linked
33%
Dynamics
33%
T Cell
33%
Cytotype
33%
Sirtuin
33%
Arginine
33%
Lysine
33%
Gene Targeting
33%
KEAP1
33%
Synapse
33%
Cisplatin
33%
Azacitidine
33%
SMARCA2
33%
SMARCA4
33%
Tumor Progression
31%
Gene Expression
24%
T Cell Receptor
20%
DNA Library
20%
Histone Modification
14%
Cancer Cell
14%
Transcriptomics
14%
Promoter Region
13%
Human Papillomavirus Type 16
13%
Chromatin Remodeling
11%
Glutaminase
11%
Wild Type
11%
Glutamine
11%
Western Blot
11%
Nude Mouse
11%
Metabolic Pathway
11%
Mouse Model
11%
Immunostaining
11%
Transfection
11%
Exome Sequencing
11%
Clonal Evolution
11%
Aggression
11%
Genetics
10%
DNA Methyltransferase
9%
EZH2
9%
Cell Mutant
8%
Stem Cell
7%
Progenitor Cell
7%
Medicine and Dentistry
Neoplasm
69%
Tumor Cell
46%
Head and Neck Squamous Cell Carcinoma
33%
Drug Response
33%
Drug Delivery System
33%
Malignant Peripheral Nerve Sheath Tumor
33%
Cisplatin
33%
Biological Marker
33%
Connective Tissue Cancer
33%
Ovarian Cancer
33%
Metastatic Carcinoma
33%
Acute Myeloid Leukemia
33%
Natural Killer Cell
33%
Cell Line
20%
In Vitro
20%
Distant Metastasis
20%
Tumor Progression
17%
Gene Expression
16%
Tumour Heterogeneity
13%
Drug Efficacy
12%
Drug Screening
12%
Curcumin
11%
Myeloid Malignancy
11%
Transcriptomics
10%
Cellular Model
8%
Subcutaneous Injection
8%
Implant
8%
Xenograft
8%
Glutaminase
6%
Exome Sequencing
6%
Western Blot
6%
Cancer Therapy
6%
Flow Cytometry
6%
Health Care Cost
6%
Cell Heterogeneity
6%
Head and Neck Tumor
6%
Cancer Stem Cell
6%
Immunohistochemistry
6%
Target Identification
6%
Tongue
6%
Glutamine
6%
NRF2/KEAP1 Pathway
6%
Drug Repositioning
6%
Oral Cancer
6%
Cell Signaling Pathway
6%
Head and Neck Squamous Cell Carcinoma Cell Line
6%
Aggression
6%
Squamous Cell Carcinoma Cell
6%
Regeneration
5%
Histone Modification
5%